ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Simvastatin Inhibits Tumor Growth and Migration by Mediating Caspase-1-Dependent Pyroptosis in Glioblastoma Multiforme

Yang, Shulong; Xie, Chuncheng; Guo, Tieyun; Li, Huiying; Li, Nannan; Zhou, Song; Wang, Xiuyun; Xie, Chuncheng哈尔滨医科大学; 1
World Neurosurgery2022-9DOI: 10.1016/j.wneu.2022.03.089
8被引6阅读
引用收藏
分享

摘要

OBJECTIVES: Glioblastoma multiforme (GBM) is the most common and lethal central nervous system cancer and is associated with a poor prognosis. Simvastatin, a kind of widely used hypolipidemic agent, has been investigated for its beneficial effects on various types of cancers. The main purpose of this paper is to investigate the potential inhibitory effects of simvastatin on GBM and the underlying mechanism. @@@ METHODS: Cell viability and cell cycle of simvastatin-treated U87 and U251 cells were determined by CCK8 assay and flow cytometry, respectively. Additionally, we assessed cell migration and invasion abilities using a wound-healing assay and transwell assay. mRNA and protein expression patterns of caspase-1 and its markers nucleotide-binding oligomerization domain-like receptor pyrin domainecontaining 3 (NLRP3) and IL-1 beta in different conditions were detected by real-time polymerase chain reaction, immunofluorescence staining, and Western blot. @@@ RESULTS: Simvastatin decreased the viability of GBM cells and inhibited cell migration and invasion in a dose-dependent manner. Moreover, suppression of pyroptosis, as characterized by decreased expression of caspase-1, NLRP3, and IL-1 beta, was observed. However, use of an miR-214 inhibitor reversed the simvastatin suppressive effect on GBM cells. @@@ CONCLUSIONS: Simvastatin inhibits GBM progression by suppressing caspase-1-dependent pyroptosis, regulated by miR-214.

学科与关键词

关键词
Caspase-1Glioblastoma multiformemiR-214PyroptosisSimvastatin
相关
加载中…
  • VSIG4 Silencing Inhibits Glioblastoma Growth by Regulating the JAK2/STAT3 Pathway
    Zheng, Congying; Mao, Chengliang; Tang, Kai; Shu, Hang*Neuropsychiatric Disease and Treatment, 2023, 19: 1397-1408.被引 1
  • CCL2-targeted ginkgolic acid exerts anti-glioblastoma effects by inhibiting the JAK3-STAT1/PI3K-AKT signaling pathway
    Chen, Xi; Zhu, Mingwei; Zou, Xiaomeng; Mao, Yingxuan; Niu, Jiamei; Jiang, Jian; Dong, Tianxiu; Shi, Ying; Yang, Xiuhua*; Liu, Pengfei*Life Sciences, 2022, 311: 121174.被引 2
  • 辛伐他汀对胶质瘤U251细胞侵袭及其MMP2表达的影响
    徐超; 徐善才; 郑天虎; 史怀璋现代肿瘤医学, 2013, (08): 1677-1679.
查看全部 →

发表信息

论文状态
公开发表
期刊
World Neurosurgery
发表日期
2022-09
卷期
第 165 卷
页码
E12-E21
DOI
10.1016/j.wneu.2022.03.089
语言
ENGLISH
期刊等级
4区
成果收录
SCIE

作者

  • Y

    Yang, Shulong (第一作者)

    2 · harbin med univ

  • X

    Xie, Chuncheng

查看全部 8 位作者收起作者
  • G

    Guo, Tieyun

    harbin med univ

  • L

    Li, Huiying

    1 · harbin med univ

  • L

    Li, Nannan

    1 · harbin med univ

  • Z

    Zhou, Song

    1 · harbin med univ

  • W

    Wang, Xiuyun

    1 · harbin med univ

  • X

    Xie, Chuncheng

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417